CAMPBELL, California, May 27, 2026, 06:04 (PDT)
Arteris Inc. stock hovered close to its 52-week high in Nasdaq premarket action Wednesday, with the semiconductor-design software maker finishing Tuesday up 4.5% at $37.91. Shares were last seen at $38.15 as of 9:00 a.m. Eastern, a few cents shy of the 52-week high of $38.47.
Chip-linked small caps are still seeing heavy demand from investors, with the artificial intelligence trade pushing up big tech stocks. U.S. stock futures traded higher ahead of the open, and Nasdaq 100 futures led gains, driven by ongoing AI optimism in semiconductors and software.
Nasdaq was open, with no holiday closing. Regular trading started at 9:30 a.m. Eastern and wrapped at 4:00 p.m., and pre-market trading was from 4:00 a.m. to 9:30 a.m. Nasdaq’s 2026 holiday calendar has Memorial Day on Monday, May 25. Wednesday is not a listed closed day.
Regulatory news drove the latest move for Arteris, not operations. The company’s investor-relations site posted two Form 144 filings on May 26. Both filings were classified as insider notifications before planned restricted stock sales.
Form 144 is a filing that signals someone plans to sell restricted or control shares under Rule 144. It doesn’t show the shares are actually sold yet. By federal rule, the form is tied to proposed sales through Rule 144, and it’s usually not needed if the planned sale is no more than 5,000 shares or $50,000 in three months.
Arteris shares moved higher after the company’s first-quarter results on May 12. Revenue rose 39% to $22.9 million from a year earlier, with the company raising its 2026 revenue target to a range of $91 million to $95 million. CEO K. Charles Janac said it was a “strong first quarter.” CFO Nicholas Hawkins said Arteris was “well positioned for the future” as he disclosed plans to retire on Aug. 31. Arteris, Inc.
Arteris sells network-on-chip technology, known as NoC, plus system-on-chip integration tools. Last week, the company said Li Auto used Arteris FlexNoC 5 and Magillem software in the autonomous-driving chip for its L9 Livis SUV. Li Auto executive Luo Min said Arteris “plays a key role” in its strategy. Arteris, Inc.
Arteris faces a tough market. Its filings show it mostly goes up against in-house chip design teams at its customers, as well as bigger third-party players like Arm and Cadence that have stronger engineering and more cash. But Arteris also said those same big companies can work with it on some chip designs, so it’s not just a clean list of competitors.
But there’s a risk the stock is outpacing the business. Arteris is still reporting GAAP losses, and even routine insider sales can dent sentiment. A pause in customer chip projects, weaker automotive AI demand or slower licensing renewals would pressure a company with a valuation that tolerates little delay.
Price targets aren’t far from where the stock is now. MarketBeat says four analysts have an average 12-month target of $37.75. The highest is $40, the lowest is $35. That puts upside limited from Tuesday’s close.
